Nanofabricated particles for engineered drug therapies:: A preliminary Biodistribution study of PRINT ™ nanoparticles

被引:195
作者
Gratton, Stephanie E. A.
PohhauS, Patrick D.
Lee, Jin
Guo, Ii
Cho, Moo J.
DeSimone, Joseph M.
机构
[1] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
[3] N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
PRINT; biodistribution; nanoparticles; pharmacokinetics; nanomedicine;
D O I
10.1016/j.jconrel.2007.05.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A novel method for the fabrication of polymeric particles on the order of tens of nanometers to several microns is described. This imprint lithographic technique called PRINT (TM) (Particle Replication In Non-wetting Templates), takes advantage of the unique properties of elastomeric molds comprised of a low surface energy perfluoropolyether network, allowing the production of monodisperse, shape-specific nanoparticles from an extensive array of organic precursors. This engineered nature of particle production has a number of advantages over the construction of traditional nanoparticles such as liposomes, dendrimers, and colloidal precipitates. The gentle "top down" approach of PRINT enables the simultaneous and independent control over particle size and shape, composition, and surface functionality, and permits the loading of delicate cargos such as small organic therapeutics and biological macromolecules. Thus, this single tool serves as a comprehensive platform for the rational design and investigation of new nanocarriers in medicine, having applications ranging from therapeutics to advanced diagnostics. Preliminary in vitro and in vivo studies were conducted, demonstrating the future utility of PRINT particles as delivery vectors in nanomedicine. Monodisperse 200 nm poly(ethylene glycol)-based (PEG) particles were fabricated using PRINT methodology and characterized via scanning electron microscopy and dynamic light scattering. Incubation with HeLa cells showed very little cytotoxicity, even at high concentrations. The biodistribution and pharmacokinetics of [I-125]-labeled particles were studied in healthy mice following bolus tail vein administration. The particles were distributed mainly to the liver and the spleen with an apparent distribution t(1/2) of approximately 17 min followed by slow redistribution with a t(1/2) of 3.3 h. The volume of distribution for the central and peripheral compartments was found to be approximately 3 mL and 5 mL, respectively. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 33 条
[1]   PHARMACOKINETICS OF LONG-CIRCULATING LIPOSOMES [J].
ALLEN, TM ;
HANSEN, CB ;
DEMENEZES, DEL .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :267-284
[2]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[3]   Adding the third dimension to virus life cycles: Three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs [J].
Baker, TS ;
Olson, NH ;
Fuller, SD .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1999, 63 (04) :862-+
[4]   Liposome application: problems and prospects [J].
Barenholz, Y .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2001, 6 (01) :66-77
[5]   5-(3-CARBOXYMETHOXYPHENYL)-2-(4,5-DIMETHYLTHIAZOLYL)-3-(4-SULFOPHENYL)TETRAZOLIUM, INNER SALT (MTS) AND RELATED ANALOGS OF 3-(4,5-DIMETHYLTHIAZOLYL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE (MTT) REDUCING TO PURPLE WATER-SOLUBLE FORMAZANS AS CELL-VIABILITY INDICATORS [J].
BARLTROP, JA ;
OWEN, TC ;
CORY, AH ;
CORY, JG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (11) :611-&
[6]   BETA-2-GLYCOPROTEIN-I IS A MAJOR PROTEIN ASSOCIATED WITH VERY RAPIDLY CLEARED LIPOSOMES IN-VIVO, SUGGESTING A SIGNIFICANT ROLE IN THE IMMUNE CLEARANCE OF NON-SELF PARTICLES [J].
CHONN, A ;
SEMPLE, SC ;
CULLIS, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25845-25849
[7]  
Drummond DC, 1999, PHARMACOL REV, V51, P691
[8]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[9]   Imparting size, shape, and composition control of materials for nanomedicine [J].
Euliss, Larken E. ;
DuPont, Julie A. ;
Gratton, Stephanie ;
DeSimone, Joseph M. .
CHEMICAL SOCIETY REVIEWS, 2006, 35 (11) :1095-1104
[10]   Engineering liposomes for drug delivery: Progress and problems [J].
Gregoriadis, G .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) :527-537